Tekla Life Profile

USD 0.05  0.26%

Purchase by Kent Thomas M of 1300 shares of Tekla Life

Tekla Life Sciences Investors insider trading alert for perchase of shares of beneficial interest by Kent Thomas M, the corporate stakeholder, on January 29, 2018. This event was filed by Tekla Life Sciences Inves with SEC on 2018-01-29. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Tekla Life Summary

Tekla Life Sciences Investors (HQL) is traded on New York Stock Exchange in USA. It is located in 2 Liberty Square and employs 13 people. The company currently falls under 'Small-Cap' category with total capitalization of 423.44 M. Tekla Life Sciences Investors has 21.17 M outstanding shares of which 76.57 K shares are currently shorted by investors with about 0.0 days to cover shorted positions. HQ LIFE SCIENCES has about 615.31 K in cash with (12.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.85.
Check Tekla Life Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 19.19HorizonTargetOdds Above 19.19
90.39%30 days 19.19 9.16%
Based on normal probability distribution, the odds of Tekla Life to move above current price in 30 days from now is about 9.16% (This Tekla Life Sciences Investors probability density function shows the probability of Tekla Life Stock to fall within a particular range of prices over 30 days) .

Tekla Life Sciences Risk Profiles

Key Fundamentals

Tekla Life Against Markets

Current Ratings

Tekla Life 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Tekla Life Sciences Investors are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Tekla Life operates under Closed-End Fund - Equity classification in USA and traded on New York Stock Exchange. more
NameTekla Life Sciences Investors
PresidentDaniel OmsteadView All
Macroaxis Advice
InstrumentUSA Stock View All
Business Address2 Liberty Square
ExchangeNew York Stock Exchange
Contact Number617 772 8500
CurrencyUSD - US Dollar

Did you try this?

Run Portfolio Volatility Now

Portfolio Volatility

Check portfolio volatility and analyze historical return density to properly model market risk
All  Next Launch Portfolio Volatility

Diversify with Tekla Life Sciences Investors

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tekla Life Sciences Investors to your portfolio


Tekla Life Corporate Management
William Reardon Independent Trustee, CPA
Michael Bonney Independent Trustee
Oleg Pohotsky Independent Trustee, MBA
Lucinda Stebbins Independent Trustee, CPA
Uwe Reinhardt Independent Trustee, Ph.D
Rakesh Jain Independent Trustee
Please also check Risk vs Return Analysis. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.